Home/Filings/4/0000707549-23-000095
4//SEC Filing

Vahedi Vahid 4

Accession 0000707549-23-000095

CIK 0000707549other

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 4:45 PM ET

Size

354.2 KB

Accession

0000707549-23-000095

Insider Transaction Report

Form 4
Period: 2023-08-01
Vahedi Vahid
Senior Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2023-08-01$190.07/sh+3,576$679,69030,059 total
  • Sale

    Common Stock

    2023-08-01$717.53/sh3,576$2,565,88026,483 total
  • Exercise/Conversion

    Common Stock

    2023-08-01$176.75/sh+7,432$1,313,60633,915 total
  • Sale

    Common Stock

    2023-08-01$717.52/sh7,432$5,332,60926,483 total
  • Exercise/Conversion

    Common Stock

    2023-08-01$300.33/sh+2,748$825,30729,231 total
  • Sale

    Common Stock

    2023-08-01$717.23/sh2,748$1,970,94826,483 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2023-08-013,5760 total
    Exercise: $190.07Exp: 2025-03-01Common Stock (3,576 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2023-08-017,4320 total
    Exercise: $176.75Exp: 2026-03-01Common Stock (7,432 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2023-08-012,7480 total
    Exercise: $300.33Exp: 2027-03-02Common Stock (2,748 underlying)
Footnotes (6)
  • [F1]The amount reported includes shares subject to unvested restricted stock units.
  • [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $717.26 to $718.10, inclusive.
  • [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $716.91 to $717.32, inclusive.
  • [F4]The stock option becomes exercisable in three equal installments on 03/01/2019, 03/01/2020, and 03/01/2021.
  • [F5]The stock options will become exercisable in three equal installments on 03/01/2020, 03/01/2021, and 03/01/2022.
  • [F6]The stock option becomes exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023.

Issuer

LAM RESEARCH CORP

CIK 0000707549

Entity typeother

Related Parties

1
  • filerCIK 0001707826

Filing Metadata

Form type
4
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:45 PM ET
Size
354.2 KB